With reference to letter dated August 10, 2020, wherein the Company had informed that the Interim Dividend declared by the Board of Directors at their meeting held on August 10, 2020 shall be paid on or before September 8, 2020, Astrazeneca Pharma India has confirmed that the Company has completed dispatch of interim dividends through electronic mode to all those shareholders whose bank accounts were registered with the Company/ Depositories. However, with regard to those shareholders whose bank account details are not registered the physical instruments for the dividends are being dispatched to their registered address. In view of the current COVID-19 pandemic situation, the physical dispatches is taking a slightly longer time than usual. The Company is making best efforts to ensure that the physical instruments/ DDs are dispatched within best possible timelines.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: